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Early gastric cancer mimicking advanced gastric cancer
K Kitamura, T Yamaguchi, S Nishida, K Yamamoto, K Okamoto, H Taniguchi, A Hagiwara, K Sawa! and T Takahashi
First Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto 602, Japan
Summary The clinicopathological features of 37 early gastric cancers mimicking advanced gastric cancer were reviewed retrospectively, and
were compared with 596 other early gastric cancers and 126 mp gastric cancers, defined as gastric cancer invading the muscularis propria of
the stomach. A greater tumour size (P < 0.005), submucosal invasion (P < 0.005), lymph node and lymph vessel invasion (P < 0.005) and
vascular invasion (P < 0.025) were found more frequently in early gastric cancers mimicking advanced gastric cancers than in other early
gastric cancers. There were no significant differences in the clinicopathological findings between early gastric cancers mimicking advanced
gastric cancers and mp gastric cancers. Patients with early gastric cancers mimicking advanced gastric cancers showed a lower survival rate
than patients with other early gastric cancers, but a higher survival than those with mp gastric cancers. The macroscopic appearance of an
advanced gastric cancer was an indicator of massive submucosal invasion and lymph node metastasis in early gastric cancer. As early
gastric cancers mimicking advanced gastric cancers showed similar clinicopathological findings to mp gastric cancers, these cancers should
be treated as mp gastric cancers.
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Recent advances over the last two decades in diagnostic tech-
niques have led to an increased incidence ofthe early detection of
gastric cancers. Early gastric cancer (EGC) now accounts for over
50% ofall gastric malignancies in most Japanese hospitals (Hioki
et al, 1990; Maehara et al, 1992). As these incidences have
increased, the clinicopathological features of EGCs have been
gradually elucidated by various authors (Mori et al, 1985; Ohta et
al, 1987; Moreaux et al, 1993). The accumulation ofpatients with
EGCs has allowed the investigation ofatypical EGCs (Noguchi et
al, 1985; Ichiyoshi et al, 1990; Kitamura et al, 1996a); early
gastric cancers mimicking advanced gastric cancers (EGC
mimicking AGC) is one such variant.
The majority of EGCs are small in size and less invasive,
suggesting that extended surgery including extensive lymph node
dissection is not imperative for the treatment of EGCs. Lymph
node metastasis in EGCs is infrequent, and is generally no more
than 10% (Hioki et al, 1990; Maehara et al, 1992; Kitamura et al,
1995a). This low frequency indicates that extensive lymph node
dissection is not required for the surgical treatment ofthe majority
of EGC cases. A number of previous studies have shown that
patients with EGCs have an excellent survival prognosis, and the
recurrence rate is under 10% in most Japanese hospitals (Hioki et
al, 1990; Maehara et al, 1992). The observations mentioned above
are reflected by a recent trend in the surgical treatment forpatients
with EGCs: it is currently common to choose a surgical procedure
such as limited surgery so that a complete cure is achieved and the
patient's quality of life is improved (Ichiyoshi et al, 1990;
Kitamura et al, 1995b). However, this type ofsurgical procedure is
not uniformly applicable for every EGC. EGCs with massive sm
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invasion may represent one EGC variant for which limited surgery
is not indicated. This study was designed to determine the clinico-
pathological features of EGCs mimicking AGC, the relation of
these cancers with massive submucosal invasion and appropriate
surgical procedure for these cancers.
PATIENTS AND METHODS
Patients
From 1969 to 1994, a total of 1691 patients with gastric cancer
were admitted to First Department of Surgery, Kyoto Prefectural
University of Medicine. Of these 1691 patients, 633 were diag-
nosed as having EGCs, which were defined as a lesion with
a depth of invasion limited to the mucosa or to the mucosa
plus submucosa of the stomach (Japanese Research Society for
Gastric Cancer, 1981). Of these 633 patients, 37 (5.8%) were
diagnosed preoperatively with AGC by a barium radiograph, an
endoscopic examination and intraoperative inspection of the
resected specimen. These 37 gastric cancers were defined as EGCs
mimicking AGCs.
Methods
The clinicopathological features of these 37 patients with EGCs
mimicking AGCs were compared with those ofthe remaining 596
patients with EGCs, and against the 126 patients with gastric
cancers that invaded the muscularis propria (mp) of the stomach.
The macroscopic and microscopic classifications of early gastric
cancer were based on the general rules for Gastric Cancer Study in
Japan. Tumour size was expressed as the major axis measured on
the resected specimens. Histopathological examinations were also
performed on the primary lesions using serial sections to deter-
mine their histological features. The resected lymph nodes were
also examined using three central sections to confirm the presence
ofmetastasis.
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Figure 1 Macroscopic appearance of EGCs mimicking AGCs. (A), Polypoid tumour; (B), ulcerated tumour with sharply demarcated and raised margins;
(C and D), non-classified tumours that could not be classified into any of the Borrmann types
Statistical analysis
Statistical analysis regarding the clinicopathological findings was
performed using the chi-square test. The cumulative survival rates
were calculated by the Kaplan-Meier method. A P-value of less
than 0.05 was considered to be statistically significant.
RESULTS
Macroscopic appearance of EGCs mimicking AGCs
Thirty-seven, EGCs were diagnosed as advanced gastric cancers
by barium radiograph, endoscopic examination and intraoperative
inspection of the resected specimen. These diagnoses were based
on the clinical findings, including a greater tumour size, scirrhous
changes of the gastric wall and the presence of a deep ulcer. The
macroscopic types ofthe 37 EGCs simulating AGCs were grouped
according to the Borrmann classification: (1) six cases ofBorrman
type I (Figure IA); (2) 12 cases of Borrmann type II (Figure 1B);
(3) one case of Borrmann type III; (4) one case of Borrmann type
IV and (5) 17 cases ofan unclassified type (Figure lB and D).
Clinicopathological characteristics
The clinicopathological features of the 37 EGCs mimicking AGC
were compared with those of the 596 other EGCs and the 126 mp
gastric cancers; these details are shown in Table 1. The tumour
size of the EGCs mimicking AGCs was greater than the other
EGCs (P < 0.005). Submucosal invasion was also more prominent
in EGCs mimicking AGCs than in the other EGCs (P < 0.005),
and lymph node and lymph vessel involvement was more
frequent (P < 0.005). Vascular invasion was also higher in EGCs
mimicking AGCs than in the other EGCs (P < 0.025). There was
no difference in histological type between the two groups. With
respect to the surgical procedure used, a total gastrectomy with
extensive lymph node dissection, defined as D2 or greater, was
performed more frequently in EGCs simulating AGCs than in the
other EGCs (P < 0.05).
There were no statistical differences in the clinicopathological
findings between EGCs mimicking AGCs and mp gastric cancers.
The frequency of lymph node metastasis in EGCs simulating
AGC was almost identical to that of mp gastric cancers (37.8%
vs 39.7%).
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Table 1 Clinicopathological findings of EGCs mimicking AGCs
Variable EGCs Other EGCs mpgastric P.value
mimicking (%) cancers
AGCs (%) (%)
sml
m
Case
Gender
Male
Female
Location
Upper
Middle
Lower
Unknown
Tumour size (cm)
0-2
2.1-4.0
4.1-6.0
6.1-Unknown
Gastrectomy
Partial
Distal
Proximal
Total
Lymph node dissection
DO
Dl
D2
D3 or greater
Depth of invasion
Mucosal
Submucosal
Histological type
Intestinal
Diffuse
Unknown
Lymph node metastasis
Positive
Negative
Unknown
Lymph vessel invasion
aZZZZ 37 596 126
28 (75.7) 410 (68.8) 84 (66.7)
9 (24.3) 186 (31.2) 42 (33.3)
3 (8.1)
13 (35.1)
21 (56.8)
0
54 (9.4)
297 (51.5)
226 (39.2)
19
3 (8.1) 263 (44.6)
16 (43.2) 237 (40.2)
15 (40.5) 72 (12.2)
3 (8.1) 18 (3.1)
0 6
0 13 (2.4)
32 (86.5) 500 (91.4)
1 (2.7) 24 (4.4)
4 (10.8) 49 (9.0)
0
3 (8.1)
32 (86.5)
3 (8.1)
9 (1.5)
166 (27.9)
414 (69.5)
7 (1.2)
7 (18.9) 320 (53.8)
30 (81.1) 276 (46.3)
19 (51.4) 358 (64.6)
18 (48.6) 196 (35.4)
0 42
14 (37.8)
23 (62.2)
0
37 (6.4)
543 (93.6)
16
23 (19.2)
41 (34.2)
56 (46.7)
6
NS
sm
S
NS
P < 0.005ab sm2
24 (19.5)
52 (42.3)
31 (25.2)
16 (13.0) Z
3
0
90 (71.4)
11 (8.7)
25 (19.8) P< 0.005b
P < 0.005a,b
2 (1.6)
18 (14.3)
96 (76.2)
10 (7.9)
P < O.005a
NS
75 (60.5)
49 (39.5)
2
P < 0.005a.b
50 (39.7)
76 (60.3)
sm
PM
,%%.- ~~~~~~~~~~~~S
sm3
sm
_>pmp
PM
Figure 2 Subdivision of the submucosal cancers according to the extent of
<0.025k
cancer invasion. (A) sml, slight invasion limited to the upper submucosa;
p <0.005a 13(B) sm2, moderate invasion into the middle of the submucosa; (C) sm3 deep
P < QQQ05b invasion close to the muscular layer
Positive
Negative
Unknown
Vascular invasion
Positive
Negative
Unknown
Survival
Alive
Death
Peritonitis
carcinomatosis
Liver metastasis
Local recurrence
Undefined recurrence
Operative death
Other disease
15 (40.5) 37 (9.4) 29 (43.9)
22 (59.5) 357 (90.6) 37 (56.1)
0 202 60
4 (10.8)
33 (89.2)
0
12 (3.1)
378 (96.9)
206
P < 0.005a,b
13 (19.7)
53 (80.3)
60
34 489 91
5 107 35
2
2
0
1
0
0
4
3
0
11
4
85
7
1
11
11
Figure 3 Typical histological findings of an sm3 tumour. Cancer cells
invaded into the submucosal layer extensively
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NS, not stastical; aEGCs mimicking AGC vs other EGCs; bmp gastric cancers
vs other EGCs. Survivals of patients were investigated in June 1995.
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Figure 4 Survival rates of patients with EGCs mimicking AGCs. The
postoperative survival rate of patients with EGCs mimicking AGCs was
intermediate between patients with other EGCs and mp gastric cancers
The extent of submucosal invasion
Ofthe 37 EGCs mimicking AGCs and the other 596 EGCs, 30 and
320 cases, respectively, had cancer invasion to the submucosal
layer of the stomach. The extent of submucosal invasion was
examined in the 30 EGCs mimicking AGCs and in 100 solitary
submucosal EGCs ofanother type. Submucosal invasion was clas-
sified into three subgroups according to the extent of invasion
(Figure 2, Inove et al, 1991): (1) sml, slight invasion limited to the
upper submucosa; (2) sm2, moderate invasion into the middle of
the submucosa and (3) sm3, deep submucosal invasion close to the
muscular layer. Five (16.7%), eight (26.7%) and 18 (60%) lesions
were classified as sml, sm2 and sm3 respectively, in the EGCs
mimicking AGCs. In contrast, 43 (43%), 34 (34%) and 24 (24%)
lesions were classified as sml, sm2 and sm3, respectively, in the
other EGCs. Of the 14 node-positive EGCs mimicking AGCs, 11
cases (78.6%) were sm3. The typical histology of sm3 invasion is
shown in Figure 3.
Survival rate
The post-operative survival rate ofpatients with EGCs mimicking
AGCs was intermediate between patients with other EGCs and
patients with mp gastric cancers (Figure 4). The 5-year survival
rates were 76%, 89% and 95% in patients with mp gastric cancer,
those with EGCs mimicking AGCs and those with other EGCs
respectively. The 10-year survival rates were 71%, 87%, and
92% in mp gastric cancer, EGCs mimicking AGCs, and the other
EGC groups. There was a significant difference in the 5-year and
10-year survival rates between the other EGC patients and mp
gastric cancer patients (P < 0.05), but no difference in those rates
between patients with EGCs mimicking AGC and mp gastric
cancer patients.
DISCUSSION
The most predominant pathological feature of EGCs mimicking
AGCs was a higher incidence of lymph node metastasis in
comparison with the other types ofEGCs; 37.8% for EGCs mimic-
king AGCs versus 6.4% for the other EGCs. Several factors have
been reported to be correlated with lymph node metastasis in
gastric cancer: tumour size, the depth of invasion, lymph vessel
invasion and histological type (Hioki et al, 1990; Maehara et al,
1992). Our study revealed that, of these factors, a greater tumour
size, massive sm invasion and frequent lymph vessel invasion
were more prominent in EGCs mimicking AGCs than in the other
EGCs. In our previous report, a multivariate analysis using a
logistic regression adjustment showed that among these three
factors, the last two were independent risk factors for lymph node
metastasis in early gastric cancer (Kitamura et al, 1996b). In
particular, massive sm invasion was strongly associated with
lymph node metastasis in EGC. In the present study, massive sm
invasion was particularly frequent when EGCs mimicking AGCs
also had lymph node metastasis. This result is explainable by the
observation that the submucosal layer of the stomach is rich in
lymphatic capillaries (Inoue et al, 1991; Maehara et al, 1992; Sano
et al, 1992).
We showed that 60% of EGCs simulating AGC had sm3 inva-
sion, whereas 24% of the other EGCs had sm3 invasion. The rate
of sm3 invasion in EGCs mimicking AGCs is apparently higher
than that of the other EGCs; this has also been described in other
reports (Miyamoto et al, 1987; Ikeguchi et al, 1989). We also
showed that the rate of sm3 invasion accounted for 78.6% of
EGCs mimicking AGCs when they were complicated by lymph
node metastasis. The higher frequency of sm3 invasion in EGCs
mimicking AGCs indicates that these tumours readily produce
massive sm invasion, and as a result lead to more frequent lymph
node metastasis.
The histological findings of the EGCs mimicking AGCs
mentioned above were strongly connected with their macroscopic
appearance; 16 ofthe 37 cancers had a macroscopic appearance of
an unclassified type according to the Borrmann classification. The
macroscopic appearance was characteristic of a greater tumour
size, the presence of a deep ulcer and scirrhous changes in the
gastric wall. We found thatthe cancerlesions with adeep ulcer and
scirrhous changes were often accompanied by histological
destruction of the normal gastric architecture. This histological
destruction might allow the cancer cells to invade into the deeper
zone ofthe gastric wall and to produce massive sm invasion. Thus,
the macroscopic appearance described above is a useful predictor
for massive sm invasion and lymph node metastasis in early
gastric cancer.
Patients with EGCs mimicking AGCs showed an intermediate
post-operative survival rate between patients with mp gastric
cancer and those with other EGCs. Because ofthe limited number
ofpatients with EGCs mimicking AGCs, it is currently difficult to
calculate their post-operative prognosis precisely. However, we
believe that the post-operative prognosis in patients with EGCs
mimicking AGCs is similar to that in patients with mp gastric
cancers, because the clinicopathological findings are very similar
in the two groups. This congruence ofclinicopathological findings
would be reflected by the biological behaviour of the tumour in
groups, and also by their post-operative survival rate. Above all, it
is worth mentioning that the frequency of lymph node metastasis
was similar in the two groups. Lymph node metastasis is the most
reliable prognostic factor in gastric cancers when the depth of
invasion is similar (Maruyama et al, 1987; Hioki et al, 1990;
Maehara et al, 1992; Sano et al, 1992). The results of the clinico-
pathological findings indicate that EGCs mimicking AGCs should
be treated in a similar fashion to mp gastric cancers. Extensive
lymph node dissection should be performed on EGCs mimicking
AGCs as well as on mp gastric cancers.
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Recent advances in diagnostic techniques allowed us to deter-
mine preoperative and intraoperative staging of gastric cancer
(Tatsuta et al, 1982; Yasuda et al, 1986; Tio et al, 1989). In partic-
ular, endoscopic ultrasonography and intraoperative histological
examination are useful for more objective determination of the
depth of invasion for gastric cancer, which is strongly correlated
with patients' survival time (Maruyama et al, 1989; Kitamura et al,
1996c). Preoperative and intraoperative assessment ofthe depth of
invasion is imperative for determining the surgical procedure:
limited or extensive lymph node dissection. In recent years, we
have routinely used endoscopic ultrasonography to gauge the
depth of invasion, and sometimes intraoperative frozen section.
These examinations will become more important for determining
the appropriate surgical procedure for early gastric cancer in
future. However, these examinations may be rather disadvanta-
geous fordetermining the appropriate surgical procedure forEGCs
mimicking AGC, considering their clinicopathological features.
These cancers should be treated as advanced gastric cancer ifthey
were diagnosed with early gastric cancer by endoscopic ultra-
sonography and intraoperative histological examination.
In conclusion, the present study demonstrated that macroscopic
appearance is auseful predictor ofmassive sm invasion and lymph
node metastasis in EGC. As EGCs mimicking AGCs are similar to
mp gastric cancers in their clinicopathological features, these
cancers should be treated as mp gastric cancers.
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